48 Biggest Movers From Yesterday

Check out these big movers of the day

Check out these penny stocks insiders are buying

Losers

• China Finance Online Co. Limited (NASDAQ:JRJC) shares tumbled 38.3% to close at $3.99 on Thursday after the company announced it has received a notice of delisting from Nasdaq.
• Peloton Interactive, Inc. (NASDAQ:PTON) dipped 23.9% to close at $24.22 following a CNBC report suggesting the company is temporarily halting production of its connected fitness products as a result of waning consumer demand.
• Valneva SE (NASDAQ:VALN) fell 20.8% to close at $37.66. Valneva shares jumped 45% on Wednesday after results from an initial laboratory study demonstrated that serum antibodies induced by three doses of Valneva's COVID-19 vaccine candidate, VLA2001, neutralize the omicron variant.
• OceanPal Inc. (NASDAQ:OP) dropped 20.3% to settle at $1.18.
• Splash Beverage Group, Inc. (NYSE:SBEV) dipped 19.4% to close at $3.19. Splash Beverage Group jumped 22% on Wednesday after the company announced it has received authorization to sell its Pulpoloco Sangria line in 187 of Ralph's Grocery stores.
• Revelation Biosciences, Inc. (NASDAQ:REVB) dropped 18.5% to close at $3.70. Revelation Biosciences said first group of patients have been dosed in Phase 2b viral challenge study to assess efficacy of intranasal REVTx-99 for the prevention of H3N2 influenza infection.
• Cognition Therapeutics, Inc. (NASDAQ:CGTX) fell 18.3% to close at $4.14.
• Star Equity Holdings, Inc. (NASDAQ:STRR) shares fell 18.1% to close at $1.36 after the company reported pricing of $14.25 million underwritten public offering.
• BTCS Inc. (NASDAQ:BTCS) dropped 17.3% to close at $5.36.
• G Medical Innovations Holdings Ltd (NASDAQ:GMVD) dipped 16.7% to close at $5.10 after jumping 45% on Wednesday. EH Hutton, on Tuesday, initiated coverage on the stock with a Buy rating and a $6 price target.
• EQRx, Inc. (NASDAQ:EQRX) dropped 16.2% to close at $4.55.
• Leap Therapeutics, Inc. (NASDAQ:LPTX) fell 16.1% to close at $2.39. Leap Therapeutics recently said it will present updated data from the DisTinGuish Phase 2a study of DKN-01, in combination with tislelizumab in gastric or gastric gastroesophageal junction cancer (G/GEJ).
• TaskUs, Inc. (NASDAQ:TASK) dropped 15.3% to close at $30.13. Spruce Point named the stock as new short call with '50% downside,' setting a $18 price target.
• Gelesis Holdings, Inc. (NYSE:GLS) fell 15.2% to settle at $4.70.
• Cardiff Oncology, Inc. (NASDAQ:CRDF) fell 15% to close at $3.87. Cardiff Oncology recently announced data from its lead clinical program evaluating onvansertib in combination with standard-of-care FOLFIRI/bevacizumab.
• Brickell Biotech, Inc. (NASDAQ:BBI) dropped 15% to close at $0.2601. HC Wainwright & Co recently initiated coverage on the stock with a Buy rating and $2 price target.
• BT Brands, Inc. (NASDAQ:BTBD) fell 14.7% to close at $2.85.
• Pluristem Therapeutics Inc. (NASDAQ:PSTI) dropped 14.6% to settle at $1.70.
• Pluristem Therapeutics and Tnuva recently announced a collaboration to establish a cultured food platform.
• Nuverra Environmental Solutions, Inc. (NYSE:NES) dipped 13.5% to close at $1.92.
• ShiftPixy, Inc. (NASDAQ:PIXY) fell 12% to close at $1.47.
• Marker Therapeutics, Inc. (NASDAQ:MRKR) fell 10.7% to close at $0.75. The company announced it received FDA Orphan Drug designation for its multi-antigen target T cell therapy for pancreatic cancer.
• Vinco Ventures, Inc. (NASDAQ:BBIG) fell 13.3% to close at $3.93 after declining around 13% on Wednesday.
• Yoshitsu Co., Ltd (NASDAQ:TKLF) shares fell 9.8% to close at $29.53.
• AppTech Payments Corp. (NASDAQ:APCX) fell 8.9% to close at $1.9946.